Related Experiment Video
Updated: May 16, 2026
08:18
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS)
Published on: December 26, 2015
Mind-body medicine for multiple sclerosis: a systematic review
Angela Senders1, Helané Wahbeh, Rebecca Spain
1Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.
Autoimmune Diseases
|December 11, 2012
Summary
Mind-body therapies show promise for managing multiple sclerosis (MS) symptoms. While evidence is limited, techniques like yoga and mindfulness are safe, non-drug options that may offer benefits for MS patients.
Area of Science:
- Neurology
- Integrative Medicine
- Psychosomatic Medicine
Background:
- Mind-body therapies are increasingly recognized for managing chronic health conditions.
- Physical and psychological symptoms significantly impact the quality of life for individuals with multiple sclerosis (MS).
Purpose of the Study:
- To systematically review the existing scientific literature on the efficacy of mind-body techniques for symptom management in multiple sclerosis.
- To evaluate the quality of evidence supporting mind-body interventions for multiple sclerosis patients.
Main Methods:
- A comprehensive literature search was conducted across major databases including MEDLINE, PsycINFO, and Cochrane Clinical Trials Register up to March 2012.
- Eleven studies investigating various mind-body modalities such as meditation, yoga, biofeedback, hypnosis, relaxation, and imagery were included in the review.
Main Results:
- Four high-quality trials focusing on yoga, mindfulness, relaxation, and biofeedback demonstrated positive effects on a range of multiple sclerosis symptoms.
- These interventions were found to be helpful in alleviating both physical and psychological distress associated with MS.
Conclusions:
- The current body of evidence for mind-body medicine in multiple sclerosis is limited but growing.
- Mind-body therapies represent a safe, non-pharmacological approach that may offer significant benefits for managing multiple sclerosis symptoms.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...